RESULTS
Study design and partnership agreement were outlined between September 2019 and January 2020. Patients from the study institution were screened for participation between March-August 2020, alongside product design and manufacture. Sixteen dogs fulfilled the inclusion criteria, and the first owner’s telephone interview was held in September 2020. Pre-clinical testing in healthy dogs occurred in early October 2020. The clinical trial ran from October 2020 to April 2021. Laboratory determinations and data analysis were subsequently undertaken.